Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs warfarin for prophylactic anticoagulation in nephrotic syndrome
ChiCTR2000036449Phase 4Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in nephrosis comparing Warfarin prophylaxis with Rivaroxaban prophylaxis (2 arms). Primary endpoints: Venous thromboembolism, Bleeding and 1 more. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
rivaroxabanwarfarin
03
Conditions
nephrosis
Beyond the preview
Go deeper on ChiCTR2000036449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036449.